Abstract Organic-inorganic hybrid nanoparticles are potential effective systems for drug delivery in cancer therapy and diagnosis. Chitosan-gum arabic with entrapped gold nanoparticles were developed as a carrier for an anticancer drug bortezomib. The nanosystem was designed to enhance the proteasome inhibitor activity in pancreatic cell lines, S2-013 and hTERT-HPNE. The hydrodynamic diameter of chitosan-gum arabic-gold nanoparticles loaded with bortezomib is around 330 nm. Laser scanning confocal microscopy images show the uptake of the gold nanoparticle/bortezomib encapsulated in chitosangum arabic matrix and the fast internalization of these nano combinations into pancreatic cells. Cytotoxic assays assessed that positively charged nanosystems reduce the cell growth and cell proliferation of S2-013s, but the same effect was not observed in cytotoxic response in hTERT-HPNE cells. The outcomes of this study demonstrate the capacity of chitosan-gum arabic nanocarriers to deliver gold nanoparticles/anticancer drug and to increase the permeation and retention effect in S2-013 cells and minimize drug side effects in HPNE cells.
Introduction
Anticancer drugs have some limitations as low stability and bioavailability that can be minimized using nanoparticles (Beija et al. 2012; Iyer et al. 2006; Liu et al. 2012) . Several studies showed that polymeric nanoparticles are suitable nanocarriers due to their high capacity of drug encapsulation and endocytosis efficiency by enhanced permeation and retention (EPR) effect (Garnett and Kallinteri 2006; Lee et al. 2013; Sinha et al. 2006) . Also, it is reported that the circulation halftime of drugs is improved and protected from inactivity during blood circulation and transport to the specific tissue (Iyer et al. 2006; Peres et al. 2012; Ruíz-Ramos et al. 2006; Yousefpour et al. 2011; Nam et al. 2009; Liu et al. 2012) . Moreover, the nanoparticles are biocompatible, stable, and non-toxic in vitro (Liu et al. 2008; Gomes et al. 2010) . The control of charged surfaces allows interactions with negatively charged components from plasma membrane, and therefore, internalization into cells by endocytosis (Beija et al. 2012; Gratton et al. 2008) . These accomplishments lead to improved drug delivery and to avoid undesirable systemic side effects in normal surrounding tissues Choi et al. 2012) . Chitosan (Ch) is a cationic polysaccharide from the partial alkaline deacetylation of chitin (Ruíz-Ramos et al. 2006; Nitta and Numata 2013; Nam et al. 2009 ). It is a biodegradable, non-toxic polysaccharide that increases cell membrane permeability, and is used in biomedical applications (Liu et al. 2012; Goodarzi et al. 2013; Moschakis et al. 2010) . Gum arabic (GA), approved by Food and Drug Administration, is an anionic polysaccharide by the exudates of acacia trees (Alvarez-Lorenzo et al. 2013; Moschakis et al. 2010 ). These polysaccharides have several suitable characteristics to improve drug nanocarriers and enhance therapeutic efficacy.
Unique properties as biocompatibility, physicalchemical stability, namely high reactive surface, and non-toxicity make gold nanoparticles (AuNPs) eligible nanosystems for cancer treatment and diagnostic applications (Ghosh et al. 2008; Patra et al. 2010; Duncan et al. 2010; Parveen et al. 2012; Huang et al. 2011) . Actually, AuNPs have been investigated for targeting drugs directly in situ, reducing several effects in the body, minimizing the multi-drug resistance (Parveen et al. 2012) . Also, AuNPs were chosen to accumulate in tumors through the EPR effect (Nitta and Numata 2013) .
The present investigation focuses on application of tumor targeting by a proteasome inhibitor, the bortezomib (BTZ), loaded in combination with pegylated gold nanoparticles (PEGAuNPs) into chitosan-gum arabic nanoparticles (Ch-GA NPs) to enhance anticancer drug activity and toxicity in cancer cells, protecting normal cells from the drug. Coelho et al. (2014) reported the BTZ surface adsorption to the PEGAuNPs led to a significant increase of BTZ toxicity with PEGAuNPs at low concentration levels. According to the cell uptake mechanism, a synergetic activity of the BTZ and AuNPs occurred. Therefore, the objective of the incorporation of bortezomib and pegylated gold nanoparticles into a positively charged chitosan-gum arabic matrix was to protect the systemic bioavailability of BTZ and avoid normal cells to be exposed to the toxicity of the drug. A technique was developed to encapsulate PEGAuNPs combined with BTZ into Ch-GA NPs matrix by complex coacervation (Coelho et al. 2011) . There are electrostatic interactions of two polysaccharides with opposite charged surface, in solution. This process is often used to encapsulate biomolecules and to control their release (Coelho et al. 2011; Moschakis et al. 2010) .
BTZ is a dipeptide boronic acid, FDA-approved inhibitor of 26S proteasome function, crucial to induce toxicity and apoptosis in tumor cells (Shahshahan et al. 2011) . Some studies showed efficacy of bortezomib in treatment of several types of cancer namely pancreatic, lung and breast cancers (Shahshahan et al. 2011) . The anticancer activity of the BTZ is expected to be enhanced by incorporation into the Ch-GA-PEGAuNPs but also to increase the systemic bioavailability of BTZ. The physicochemical properties and the in vitro cell uptake and cell growth of BTZ loaded Ch-GA-PEGAuNPs nanoparticles were studied in the human pancreatic cancer cells, S2-013 and the immortalized human pancreatic duct epithelial cells, hTERT-HPNE, by laser scanning confocal microscopy (LSCM). S2-013 is a cloned subline of a pancreatic tumor cell line, SUIT-2, derived from a liver metastasis (Iwamura et al. 1992; Tsutsumida et al. 2006) . hTERT-HPNE, derived from the primary ducts of the adult pancreas, were transduced with an catalytic subunit of human telomerase (hTERT) (Lee et al. 2003) .
Materials and methods

Materials
Chitosan 250 kDa (degree of deacetylation [ 93 %) was purchased from Altakitin (Portugal). Gum arabic (viscosity 60 mPa s), dimethyl sulfoxide (DMSO), sulforhodamine B (SRB), trypan blue, trisodium citrate dihydrate, and tetrachloroauric (III) acid (HAuCl 4 ; 99.99 % trace metals basis, 30 wt% in dilute HCl), glacial acetic acid, sodium hydroxide, and sodium chloride were from Sigma-Aldrich (Germany).
Bortezomib (Velcade) was purchased from Selleck Chemicals LLC (USA); Fetal bovine serum (FBS), phosphate buffered saline (PBS), trypsin, Dulbecco's Modified Eagle medium (DMEM), and PrestoBlue Ò Cell Viability Reagent (PB) were obtained from Invitrogen Co. (Scotland, UK). Tricloroacetic acid (TCA) and Tris buffer were acquired from Merck (Darmstadt, Germany). a-thiol-x-carboxyl (polyethylene glycol) (HS-PEG-COOH; molecular weight 394.57 Da) was purchased from Prochimia (Poland).
Methods
Synthesis of pegylated gold nanoparticles
PEGAuNPs were prepared as previously described (Coelho et al. 2013) . The concentration of the PEGAuNPs was 18.9 nM as determined by the Lambert-Beer Law assuming the molar absorptivity of the AuNPs plasmon resonance band at 526 nm being 2.33 9 10 8 M -1 cm -1 (Baptista et al. 2005 ).
Preparation of chitosan-gum arabic nanoparticles
Solutions of the complexes were prepared with the initial concentrations of Ch 0.4 % (w/v) and GA/Ch weight ratio (R GA/Ch ) of 1.2, according to the optimization previously described (Coelho et al. 2011) . Briefly, Ch solutions were prepared by dissolving the mass in 1 % aqueous acetic acid solution, followed by the pH adjustment to 4.8, with 10 % aqueous sodium hydroxide solution. GA was dissolved in ultrapure water. The complex preparation involved the mixture of aqueous phases of the two macromolecules, adding 3 mL of the corresponding GA solution to 3 mL of a Ch solution dropwise and under gentle magnetic stirring for 30 min at room temperature. The complexes pH was 4.8.
Preparation of PEGAuNPs loaded Ch-GA NPs
PEGAuNPs loaded complexes of chitosan-gum arabic were prepared in the same conditions of Ch-GA NPs. PEGAuNPs were added to the GA under magnetic stirring for 15 min at room temperature, followed by the addition of Ch solution dropwise for more 15 min. The initial concentrations of chitosan 0.4 % (w/v) and GA/Ch weight ratio of 1.2. The final PEGAuNPs concentration into Ch-GA-PEGAuNPs was 2 nM. The Ch-GA-PEGAuNPs pH was 4.7.
Preparation of BTZ loaded Ch-GA NPs (Ch-GA-BTZ NPs)
A fresh BTZ solution was prepared in DMSO at room temperature and was added to GA solution, under homogenization for 15 min at room temperature. 
Dynamic light scattering (DLS) and electrophoretic mobility measurements
Size distribution and zeta potential of the suspensions were determined by DLS and laser doppler velocimetry, respectively, using a Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, UK), keeping the samples at 25°C. Size measurements were performed at a scattering angle of 173°in a 12 mm square polystyrene cuvette (Sarstedt, Germany). The zeta potential was obtained by a disposable capillary cell (DTS 1060, Malvern).
Scanning electron microscopy (SEM) SEM (JEOL JSM-6301F, Jeol Ltd., Tokyo, Japan) was used to study the morphological properties and to confirm the size measurements of PEGAuNPs.
Transmission electron microscopy (TEM)
Five lL of each sample was placed on carbon formvarcoated grid (Formvar/Carbon on 400 Mesh Copper from Agar Scientific, UK) and stained with 1 % (w/v) of filtered uranyl acetate solution. The grids were dried at room temperature and analyzed by transmission electron microscopy (TEM, Zeiss microscope operated at 60 kV).
UV-Vis spectroscopy UV-Vis absorption measurements were carried out to confirm the BTZ and PEGAuNPs concentrations in the systems Ch-GA-PEGAuNPs, Ch-GA-BTZ NPs, and Ch-GA-BTZ?PEGAuNPs, using a 1 cm quartz cuvette, at room temperature by Shimadzu UV-1700 PharmaSpec spectrophotometer.
In vitro drug release studies BTZ release from the Ch-GA-BTZ NPs, Ch-GA-BTZ?PEGAuNPs was carried out, in vitro, at 37°C by dialysis. Dialysis was performed using a regenerated cellulose membrane, under constant magnetic stirring, with an initial BTZ concentration of 200 lM. The solutions were incubated in 6 mL of DI water and in PBS 0.01 M. BTZ concentration in the dialysate was monitored over time by UV-Vis spectroscopy (at 270 nm) and the concentration of BTZ released was calculated from the standard calibration curves of BTZ solutions in DI water and in PBS 0.01 M.
Cell culture
Human pancreatic cancer cell line (S2-013) and immortalized human pancreatic duct epithelial cells (hTERT-HPNE) were provided by Prof. M. A. Hollingsworth (UNNC -Omaha, USA). hTERT-HPNE was found to be free of cancer-associated changes or altering phenotypic properties. This type of cells was highly homogeneous for this phenotype with no evidence of ductal epithelial cells still remaining, indicating that the culture conditions were ideal for the selection and expansion of this cell type and should help to better define the biological role of this cell type (Lee et al. 2003) . The cells were maintained in DMEM medium, supplemented with 10 % FBS under 5 % CO 2 humidified atmosphere at 37°C.
In vitro cell uptake study
Imaging experiments were performed with the S2-013 and hTERT-HPNE to examine the uptake of Ch-GA-BTZ?PEGAuNPs. Briefly, 800 cells/well pancreatic cells were seeded on a l-chamber 12-well plates (ibidi, Germany), in under normal conditions (5 % CO 2 humidified atmosphere at 37°C) for attachment. After 24 h of attachment, the cells were treated with a constant BTZ concentration (100 nM) of BTZ loaded Ch-GA-PEGAuNPs for 48 h. After the incubation, the cells were rinsed with 1 % of PBS solution, to eliminate the Ch-GA-BTZ?PEGAuNPs, and fixated using 4 % paraformaldehyde for 15 min. The cells were washed with PBS and mounted on a glycerolbased non-drying and non-hardening medium. Imaging was performed by confocal imaging technique using a laser scanning confocal microscope (LSCM) TCS SP5 II (Leica Microsystems, Germany), in reflectance and transmittance mode (Joo et al. 2010; Taylor et al. 2010) . To evaluate the nanoparticle internalization in the cells, the control untreated cells were also imaged. Different areas were analyzed and at least three images were acquired for each type of cell. Cell images showed reproducible results.
In vitro cytotoxicity study
In vitro cytotoxicity of BTZ, Ch-GA NPs, Ch-GA-BTZ NPs, Ch-GA-PEGAuNPs, and Ch-GA-BTZ?PEGAuNPs against pancreatic cell lines was evaluated by two different assays based on PrestoBlue (PB) (fluorescence) and SRB (colorimetric) (Coelho et al. 2013) . Both assays allow an indirect estimation of viable cell number: the PB assay by the resazurin metabolism, and the SRB assay by staining cellular proteins with the dye SRB (Vichai and Kirtikara 2006; Skehan et al. 1990 ). Briefly, the S2-013 and hTERT-HPNE cells were seeded on 96-well plates with a cell density at 1,000 cells per well, under normal conditions (5 % CO 2 humidified atmosphere at 37°C) and allowed to adhere for 24 h. Then, the cells were treated for 48 h with BTZ, Ch-GA-BTZ NPs, and Ch-GA-BTZ?PEGAuNPs at the concentrations ranging between 0.01 and 100 nM BTZ; and Ch-GA NPs and Ch-GA-PEGAuNPs at the concentrations ranging between 1.1 9 10 -7 and 3.3 9 10 -3 mg/mL. Thereafter, 50 lL of PB reagent (diluted 1:10 in the DMEM medium) was added to each well and incubated for 45 min at 37°C. The PB reagent is modified by the reducing environment of the viable cells turning into red color and becomes fluorescent. Finally, the fluorescence was measured using a microplate reader (PowerWave HT Microplate Spectrophotometer, BioTek) at an excitation and emission wavelengths of 560 and 590 nm, respectively.
For the SRB assay, the cells were fixed with 10 % TCA for 1 h on ice. After the incubation period, the cell monolayers were washed and stained with 50 lL SRB dye for 30 min. The cells were then washed repeatedly with 1 % acetic acid to remove unbound dye. The cells were dried and the protein-bound stain was solubilised with 10 mM Tris solution. The SRB absorbance was measured at 560 nm using the PowerWave microplate reader (Skehan et al. 1990 ). Concentration for 50 % growth inhibition (GI 50 ) was evaluated from the SRB assay. The absorbance of the wells containing the nanoparticles or drug and the absorbance of the wells containing untreated cells following a 48-h incubation period were subsequently compared with that of the wells containing the cells that have been fixed at time zero (when the nanoparticles and drug were added) (Monks et al. 1991; Coelho et al. 2013) .
For each assay, three independent experiments were measured in triplicate. Statistical significance (p \ 0.05) was determined by the Student's t test.
Results and discussion
The Ch-GA-based nanoparticles alone and loaded with pegylated gold nanoparticles and BTZ were prepared through a coacervation process. Figure 1a , b confirmed the presence of PEGAuNPs inside of the complexes without and with BTZ, respectively. The Ch-GA-BTZ?PEGAuNPs show two typical absorption bands centered at 528.5 and 268.5 nm from PEGAuNPs and BTZ, respectively (data not shown). These nanosystems were stable for several weeks stored at 4°C in the dark. DLS measurements were in agreement with the TEM analysis, and are shown in Table 1 . The average hydrodynamic diameter of Ch-GA NPs ranged from 315 to 327 nm (loaded with PEGAuNPs and BTZ) and the polydispersity index (PdI) was 0.3. This diameter change occurs due to the presence of spherical PEGAuNPs with small diameters (39 nm), as depicted in Online Resource 1. In BTZ loaded Ch-GA-PEGAuNPs, no significant change in the nanoparticle diameter was observed.
The zeta potential of the mixture BTZ?PEGAuNPs was -13 ± 2 mV in water. This value is significantly different from PEGAuNPs (-39 ± 3 mV), suggesting a strong adsorption of BTZ on the PEGAuNPs surface (Coelho et al. 2013 ). The average zeta potential was positive for the different nanosystem formulations, which is attributed to the residual amine groups of Ch that neutralize the negative charges of GA and PEGAuNPs. Also, the strong positive charges on the surface of nanoparticles prevent the aggregation (Table 1) (Avadi et al. 2011 (Avadi et al. , 2010 Wang et al. 2008) .
The release profiles of BTZ from Ch-GA NPs and Ch-GA-PEGAuNPs were performed in vitro using a dialysis membrane in PBS 0.01 M at 37°C. The results are depicted in Fig. 2 . In PBS (pH 7.0), the BTZ release profile is limited by the release of the PEGAuNPs from the polysaccharide matrix explained by the delay of 5 h. Under the same conditions, the release of BTZ from PEGAuNPs also has a gap of about 2 h (Coelho et al. 2013) . For these systems, the BTZ released after 10 h was 85 %. Also, PBS provides an effect on BTZ adsorption of Ch-GA-BTZ NPs and Ch-GA-BTZ?PEGAuNPs systems, slowing down the BTZ release in the last nanoparticles.
The cellular uptake of Ch-GA-BTZ?PEGAuNPs with BTZ concentration of 100 nM in pancreatic cells (S2-013) and immortalized human pancreatic duct epithelial cells (hTERT-HPNE) was investigated through confocal microscopy. From our observations, we can conclude that PEGAuNPs were internalized and distributed throughout S2-013 and hTERT-HPNE cells after 48 h incubation, as illustrated in Fig. 3c, d .
The detection of PEGAuNPs associated to the light scattering by LSCM leads to a clear distinction between PEGAuNPs containing cells and the negative controls. It was observed that the accumulation of the nanoparticles into the cytoplasm effectively improves the cytotoxicity.
The in vitro cytotoxicity studies of the effects of Ch-GA-PEGAuNPs, Ch-GA NPs, BTZ alone, Ch-GA-BTZ?PEGAuNPs and Ch-GA-BTZ NPs were performed with S2-013 and hTERT-HPNE. The cells were exposed to a range of experimental concentration of BTZ loaded nanoparticles and blank nanoparticles for 48 h at 37°C. Their effect was evaluated by SRB and PB methods. Ch-GA-PEGAuNPs and Ch-GA NPs with Ch concentration up to 3.3 9 10 -3 mg/mL and R GA/Ch of 1.2 do not show any cytotoxicity on both cell lines (Fig. 4) , demonstrating their biocompatibility. The inhibitory effect of BTZ on proliferation of S2-013 and hTERT-HPNE was evaluated on Ch-GA-BTZ?PEGAuNPs and Ch-GA-BTZ NPs. The effect of BTZ at concentrations from 0.1 to 100.0 nM was tested in these two systems with concentrations of Ch in the range 1.1 9 10 -7 -3.3 9 10 -3 mg/mL and R GA/Ch of 1.2 (Fig. 5) . As presented in Fig. 5a , c, BTZ loaded Ch-GA NPs and BTZ loaded Ch-GA-PEGAuNPs decrease the growth rate of the S2-013 cells, when compared with BTZ alone, especially at 1.0 and 10.0 nM of BTZ concentration. A possible reason for the efficacy increase of cytotoxicity of BTZ is the efficient delivery by the nanoparticles. Ch-GA system might augment protection of BTZ. Also for 10.0 nM BTZ loaded in Ch-GA NPs and loaded in Ch-GAPEGAuNPs reduced the cell growth to about 13 % compared with 58 % to BTZ alone. This suggests that Ch-GA nanosystem efficacy might improve in vivo through the EPR effect (Nam et al. 2009) . Moreover, at this concentration range Ch-GA-BTZ?PEGAuNPs do not show toxicity to hTERT-HPNEs (Fig. 5d) .
In Table 2 , the GI 50 concentration (obtained by SRB assay) is the BTZ concentration corresponding to 50 % concentrations over 1.0 nM. In hTERT-HPNE cells an opposite effect is observed, BTZ alone is significantly (p \ 0.05) more effective, decreasing cell survival, and presents an inhibitory effect on cell growth, at the concentrations of 2 nM (Table 2) . Moreover in Fig. 6 , the percent growth is defined by the difference between viable cell and initial cell number divided by initial cell number. For values above zero, it is expected that the cells are inhibited but are not death. For values below zero, cell death is considered. This data were achieved by the following SRB assay. It is shown that BTZ loaded nanoparticles decrease significantly the S2-013 cell growth rate when compared to BTZ alone. Also, it is shown that in hTERT-HPNEs the same effect is not observed. In fact, hTERT-HPNE cell growth did not change with BTZ loaded nanoparticles in the range concentration of 0.1 and 100.0 nM (Fig. 6b ). This could be explained by the effect of carbohydrate matrix on the BTZ release in normal cells. 
Conclusion
A novel chitosan-gum arabic-gold nanoparticle system for the delivery of the proteasome inhibitor, BTZ, was developed. BTZ was entrapped into the polysaccharides-gold nanoparticles system. Confocal images suggest that Ch-GA-BTZ?PEGAuNPs were internalized by the pancreatic cells through endocytic mechanism and are able to enhance BTZ activity by permeation and retention effect. It was observed a decrease in the required drug concentration to induce cell proliferation. The in vitro cytotoxic study revealed that 10.0 nM BTZ loaded Ch-GA-PEGAuNPs had a significant toxicity to human pancreatic cancer cells as compared to the drug alone. Also, at the same BTZ concentration, the nanosystem shows no toxic effect on immortalized human pancreatic duct epithelial cells. These findings demonstrate that the organicinorganic hybrid nanoparticles developed can improve in situ drug delivery and overcome limitations associated with low bioavailability and drug side effects. Nonetheless for the potential application in cancer therapy, the nanoparticles developed can be further explored for detection of early-stage adenocarcinomas by fluorescence endoscopy as a diagnostic tool. Its utility can be enhanced by application of fluorescently tagged, biomarker-targeted nanoparticles to provide selective and specific contrast-rich imaging to maximize the security of the diagnosis. Fig. 6 Effect of the Ch-GA-BTZ?PEGAuNPs (filled circle), Ch-GA-BTZ NPs (filled squar) and BTZ alone (filled triangle) on the cell growth of S2-013 (a) and hTERT-HPNE (b) cells compared to the control, by the PB assay
